Recombinant Human B7-2/CD86 (C-Avi-6His) Biotinylated
SKU: PKSH033999-100
Recombinant Human B7-2/CD86 (C-Avi-6His) Biotinylated
SKU # | PKSH033999 |
Expression Host | HEK293 Cells |
Description
Synonyms | Activation B7-2 Antigen, B70, BU63, CD28LG2, CD86, CTLA-4 Counter-Receptor B7.2, FUN-1, T-Lymphocyte Activation Antigen CD86 |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Ala24-Pro247 |
Accession | AAH40261.1 |
Calculated Molecular Weight | 28.4 kDa |
Observed Molecular Weight | 55-80 kDa |
Tag | C-Avi-His |
Bio-activity | Not validated for activity |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | Please refer to the printed manual for detailed information. |
Background
The protein is the receptor that involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. It may play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. The protein interacts with MARCH8, human herpesvirus 8 MIR2 protein, adenovirus subgroup B fiber proteins and acts as a receptor for these viruses.It is expressed by activated B-lymphocytes and monocytes and promoted by MARCH8 and results in endocytosis and lysosomal degradation.It contains 1 Ig-like C2-type(immunoglobulin-like) domainand 1 Ig-like V-type (immunoglobulin-like) domain.